Long|term outcome and prognostic factors of second allogeneic ...

Long-term outcome and prognostic factors of second allogeneic ...

Second allogeneic hematopoietic stem cell transplantation (HSCT2) is a frequently used treatment option for relapse of acute leukemia after first allogeneic ...

Long-term outcome and prognostic factors of second allogeneic ...

Several factors have been reported to impact on the outcome after second transplant, such as younger age, absence of GvHD, chronic GvHD after ...

Outcomes and Prognostic Factors of Second Allogeneic ...

However, relapse after allo-HCT remains the main concern because it is associated with poor outcomes, with a long-term survival rate < 10 %. There is no ...

Paper: Outcomes and Prognostic Factors of Second Allogeneic ...

Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative treatment option frequently used in patients with acute lymphoblastic ...

Prognostic factors of second hematopoietic allogeneic stem cell ...

In conclusion, relapse after HSCT carries a high risk of poor outcomes for patients with hematological malignancies. However, there is some hope for selected ...

Second Allogeneic Hematopoietic Cell Transplantation for Relapsed ...

Second allogeneic hematopoietic cell transplantation (HCT2) is potentially curative for adults with acute myeloid leukemia (AML) or myelodysplastic neoplasm ( ...

Long-Term Outcome of Second Allogeneic Stem Cell ...

Long-term outcome of second allogeneic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission.

Outcomes and Prognostic Factors of Second Allogeneic ...

Allogeneic hematopoietic cell transplantation (allo-HCT) is a curative treatment option frequently used in patients with acute lymphoblastic leukemia (ALL).

Outcomes and Prognostic Factors for Patients with Relapsed or ...

With a median follow-up of 47 months (range, 8.3 to 105 months), overall survival (OS), nonrelapse mortality, and relapse mortality at 1 year were 25%, 44%, and ...

Outcomes of Second Allogeneic Hematopoietic Cell Transplantation ...

A second HCT is feasible in selected patients with AML who have relapsed after HCT1. Long-term survival benefit is possible in patients without chronic GVHD ...

Long-term outcome after allogeneic hematopoietic cell ...

-host disease (GvHD) before two years decreased the risk of relapse. Multivariable analysis of excess mortality showed that age, male sex ...

Prognostic factors for survival after allogeneic transplantation in ...

Thus, long-term survival in adults is still poor with a 5-year (y) overall survival (OS) of 30–40%, although response rates considerably ...

Reduced intensity conditioning allogeneic stem cell transplantation ...

For patients with no risk factors the 3-year non-relapse mortality rate was 12.5% compared to 46.2% for patients with 2 or more risk factors.

Long-term outcome and prognostic factors of second allogeneic ...

Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 ...

Outcomes and prognostic factors of adults with acute lymphoblastic ...

Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 ...

Allogeneic hematopoietic cell transplantation: Indications, eligibility ...

Allogeneic hematopoietic cell transplantation: Indications, eligibility, and prognosis. Formulary drug information for this topic.

Prognostic Factors Affecting Outcome after Allogeneic ... - ClinicalKey

Advanced disease was a negative factor for relapse, DFS, and OS. Donor age ≥40 adversely affected the risk of aGVHD III-IV, extensive cGVHD, and OS. Younger ...

A Study from the Adult Acute Lymphoblastic Leukemia Working ...

Request PDF | Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic ...

Long-term outcome of second allogeneic hematopoietic stem cell ...

first remission, lower Karnofsky performance status (KPS; <90) and receiving MAC at HSCT1 were adverse prognostic factors for NRM, LFS, OS, and GRFS, as was ...

Long-term health outcomes of allogeneic hematopoietic stem cell ...

In survivors of second HCT, cumulative incidence of renal failure at 2 and 10 years, respectively, for survivors transplanted before age of 18 was 1% and 4% (37) ...